OVERLAND PARK, Kan., and BOULDER, Colo., May 12, 2026
Hill’s Pet Nutrition and Bond Pet Foods have announced a major regulatory milestone after receiving a U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine Letter of No Objection for Lamb Protein Yeast, the first animal protein produced through precision fermentation approved for use in pet food. The achievement marks a significant advancement in science-driven pet nutrition and highlights growing industry momentum behind biotechnology-based alternative protein production for companion animals. The FDA’s review and no-objection response to the ingredient’s Generally Recognized as Safe (GRAS) Notice supports its use in healthy adult dog food formulations and positions the technology for broader commercial adoption in the rapidly evolving pet nutrition sector.
The newly approved ingredient was developed through a multi-year collaboration between Hill’s Pet Nutrition and Bond Pet Foods and is designed to provide a nutritionally complete animal protein source using precision fermentation technology. The companies stated that the ingredient contains a complete amino acid profile with nutritional characteristics comparable to conventional lamb protein while offering improved production scalability and sustainability benefits.
Precision Fermentation Expands Into Veterinary Nutrition
The regulatory milestone follows years of collaborative research, development, and feeding studies involving dogs. According to the companies, the FDA’s no-objection decision was supported by results from a six-month longitudinal feeding study demonstrating both safety and nutritional performance of the fermented protein ingredient in dogs. The FDA review allows the ingredient to be incorporated into finished dog food products at inclusion levels of up to 15 percent.
Precision fermentation technology has already become widely used in human food production for enzymes, vitamins, dairy proteins, and specialty food ingredients. Bond Pet Foods applies optimized yeast fermentation systems to produce animal proteins without relying on conventional livestock production methods. The resulting protein ingredient is designed to maintain nutritional quality while supporting more consistent manufacturing and potentially reducing environmental impact associated with traditional animal agriculture.
Advertisement
The companies also confirmed that feeding studies involving cats have been completed and additional regulatory submissions are currently being prepared to support future feline use approval through the FDA’s Center for Veterinary Medicine.
Science-Based Innovation Drives Future Pet Nutrition
Executives from both companies emphasized that the achievement reflects increasing demand for science-backed, sustainable nutrition solutions within the global companion animal health market. Hill’s Pet Nutrition stated that the ingredient expands its portfolio of advanced nutritional options while maintaining the company’s longstanding focus on evidence-based pet health innovation. Bond Pet Foods added that the FDA milestone demonstrates growing confidence in precision fermentation technologies as a viable long-term protein solution for the pet food industry.
The collaboration between Hill’s and Bond was originally launched in 2021 with the objective of developing alternative protein ingredients capable of meeting the dietary requirements of pets through established biotechnology processes. Since then, the companies have successfully scaled commercial production of Lamb Protein Yeast and delivered more than 25 metric tons of ingredient material for testing, formulation development, and regulatory evaluation.
Industry analysts continue to identify alternative proteins and biotechnology-enabled pet nutrition as major growth areas within the global veterinary and animal wellness sectors. Rising demand for premium pet nutrition, sustainability concerns, and advances in food biotechnology are accelerating investment into next-generation pet food ingredient platforms.
Veterinary Biotechnology Market Continues Growing
The FDA no-objection letter further validates the growing role of precision fermentation within animal nutrition and veterinary biotechnology. Companies across the pet food industry are increasingly exploring new protein production technologies capable of improving ingredient consistency, reducing supply chain risks, and addressing evolving consumer expectations around sustainability and animal welfare.
As regulatory agencies continue evaluating novel food technologies, the successful approval of Lamb Protein Yeast may help pave the way for broader adoption of biotechnology-derived ingredients in companion animal nutrition. Analysts believe the Hill’s and Bond partnership could become an important benchmark for future innovation in science-based veterinary nutrition and sustainable pet food development.
Source: Hill’s Pet Nutrition press release
